United States
Germany
Japan
United Kingdom
China
LIPG mouse monoclonal antibody, clone OTI2A5 (formerly 2A5)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human |
Antibodies
LIPG mouse monoclonal antibody, clone OTI4D2 (formerly 4D2)
| Applications | FC, IF, IHC, IP, WB |
| Reactivities | Human |
LIPG mouse monoclonal antibody, clone OTI1B8 (formerly 1B8)
| Applications | FC, IF, IHC, IP, WB |
| Reactivities | Human |
LIPG mouse monoclonal antibody, clone OTI6B11 (formerly 6B11)
| Applications | FC, IF, IHC, IP, WB |
| Reactivities | Human |
LIPG mouse monoclonal antibody, clone OTI8E4 (formerly 8E4)
| Applications | FC, IF, IHC, IP, WB |
| Reactivities | Human |
LIPG mouse monoclonal antibody, clone OTI4C1 (formerly 4C1)
| Applications | FC, IF, IHC, IP, WB |
| Reactivities | Human |
LIPG mouse monoclonal antibody, clone OTI4C3 (formerly 4C3)
| Applications | FC, IF, IHC, IP |
| Reactivities | Human |
LIPG mouse monoclonal antibody, clone OTI1E3 (formerly 1E3)
| Applications | FC, IF, WB |
| Reactivities | Human |
LIPG mouse monoclonal antibody, clone OTI4C10 (formerly 4C10)
| Applications | FC, IHC, WB |
| Reactivities | Human |
LIPG mouse monoclonal antibody, clone OTI2E7 (formerly 2E7)
| Applications | FC, WB |
| Reactivities | Human |
LIPG mouse monoclonal antibody, clone OTI6B9 (formerly 6B9)
| Applications | FC, WB |
| Reactivities | Human |
